Chainbreaker funds research on microorganisms’ role in cancer
A team of 13 physicians and scientists from the Masonic Cancer Center, University of Minnesota will study the role of the body’s own microorganisms in causing, preventing, and treating cancer, thanks to a $1.2 million grant through funds raised during the 2017 inaugural Chainbreaker bike ride.
The Chainbreaker Breakthrough Cancer Research Grant will support the group’s multidisciplinary research exploring how intestinal bacteria, viruses, and fungi influence colon cancer development and blood and marrow transplantation outcomes.
Chainbreaker is a grassroots bike tour of 25, 50, 100, or 180 miles that raises money to support Masonic Cancer Center research. In August 2018, 1,024 riders participated in the second annual Chainbreaker event, raising a projected $1.4 million — with every rider-raised dollar supporting the cause.